Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

SCIEX Biopharma & Pharma SolutionsSCIEX Biopharma & Pharma Solutions
VS
ICON plcICON plc
SCIEX Biopharma & Pharma Solutions

SCIEX Biopharma & Pharma Solutions

500 Old Connecticut Path, Framingham, 01701, US

Last Update: 28/12/2025

View Profile
Between 750 and 799
https://sciex.li/1jg90e
754/1000Fair

To bring safe and effective therapies to market, it is vital for pharma and biopharma research to have the right information available at every stage of the process. Transform your analytical workflows by collaborating with a team that is devoted to advancing pharma an...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:None
Subsidiaries:67
12-month incidents
0
Known data breaches
0
Attack type number
0
ICON plc

ICON plc

ICON plc, South County Business Park, Leopardstown, Dublin, IE, D18 X5R3

Last Update: 02/04/2026

View Profile
Between 750 and 799
http://www.iconplc.com
796/1000Fair

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with ...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:34,531
Subsidiaries:9
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
SCIEX Biopharma & Pharma Solutions

SCIEX Biopharma & Pharma Solutions

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
ICON plc

ICON plc

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for SCIEX Biopharma & Pharma Solutions in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for ICON plc in 2026.

Incidents

Incident History - SCIEX Biopharma & Pharma Solutions (X = Date, Y = Severity)

SCIEX Biopharma & Pharma Solutions cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - ICON plc (X = Date, Y = Severity)

ICON plc cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
SCIEX Biopharma & Pharma Solutions

SCIEX Biopharma & Pharma Solutions

Incidents
No explicit notable incidents reported.
ICON plc

ICON plc

Incidents
No explicit notable incidents reported.

FAQ

Between SCIEX Biopharma & Pharma Solutions company and ICON plc company, which one has the best AI Cybersecurity Score ?
Between SCIEX Biopharma & Pharma Solutions company and ICON plc company, which one has experienced more cyber incidents in the past ?
Between SCIEX Biopharma & Pharma Solutions company and ICON plc company, which one has experienced more cyber incidents this year ?
Between SCIEX Biopharma & Pharma Solutions company and ICON plc company, which one has experienced at least one ransomware attack ?
Between SCIEX Biopharma & Pharma Solutions company and ICON plc company, which one has experienced at least one data breach ?
Between SCIEX Biopharma & Pharma Solutions company and ICON plc company, which one has experienced at least one targeted cyberattack ?
Between SCIEX Biopharma & Pharma Solutions company and ICON plc company, which one has experienced at least one vulnerability ?
Between SCIEX Biopharma & Pharma Solutions company and ICON plc company, which one holds the most compliance certifications ?
Between SCIEX Biopharma & Pharma Solutions company and ICON plc company, which one holds the fewest compliance certifications ?
Between SCIEX Biopharma & Pharma Solutions company and ICON plc company, which one has the most subsidiaries ?
Between SCIEX Biopharma & Pharma Solutions company and ICON plc company, which one has the largest number of employees ?
Between SCIEX Biopharma & Pharma Solutions and ICON plc, which company holds both SOC 2 Type 1 certifications ?
Between SCIEX Biopharma & Pharma Solutions and ICON plc, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - SCIEX Biopharma & Pharma Solutions or ICON plc ?
Which company is PCI DSS compliant - SCIEX Biopharma & Pharma Solutions or ICON plc ?
Between SCIEX Biopharma & Pharma Solutions and ICON plc, which company complies with HIPAA regulations for healthcare data ?
Between SCIEX Biopharma & Pharma Solutions and ICON plc, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-26422
SUMMARY

clash-verge-service-ipc before 2.3.0 has a world-reachable IPC endpoint, leading to local privilege escalation.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 8.4)
CVSS3
Base Score: 8.4
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.5
CVE-2026-11441
SUMMARY

A vulnerability was identified in theonedev onedev up to 15.0.5. This vulnerability affects the function canAccessIssue of the file /issues/ of the component Pull Request Handler. Such manipulation of the argument issue leads to improper authorization. It is possible to launch the attack remotely. Upgrading to version 15.0.6 is able to resolve this issue. It is advisable to upgrade the affected component.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-11440
SUMMARY

A vulnerability was determined in theonedev onedev up to 15.0.5. This affects an unknown part of the file /repositories/{projectId}/default-branch of the component REST API. This manipulation of the argument project.defaultBranch causes improper authorization. It is possible to initiate the attack remotely. Upgrading to version 15.0.6 is able to mitigate this issue. Upgrading the affected component is advised.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-11439
SUMMARY

A vulnerability was found in theonedev onedev up to 15.0.5. Affected by this issue is some unknown functionality of the file /projects/ of the component Parent Project Handler. The manipulation of the argument project.parentId results in improper authorization. The attack may be performed from remote. Upgrading to version 15.0.6 can resolve this issue. It is recommended to upgrade the affected component.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-11438
SUMMARY

A vulnerability has been found in theonedev onedev up to 15.0.5. Affected by this vulnerability is an unknown functionality of the file /projects. The manipulation of the argument project.forkedFromId leads to improper authorization. The attack is possible to be carried out remotely. Upgrading to version 15.0.6 addresses this issue. Upgrading the affected component is recommended.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8